These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2619 related items for PubMed ID: 16415308

  • 1. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [Abstract] [Full Text] [Related]

  • 2. Relapses and progression of disability in multiple sclerosis.
    Confavreux C, Vukusic S, Moreau T, Adeleine P.
    N Engl J Med; 2000 Nov 16; 343(20):1430-8. PubMed ID: 11078767
    [Abstract] [Full Text] [Related]

  • 3. Age at disability milestones in multiple sclerosis.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar 16; 129(Pt 3):595-605. PubMed ID: 16415309
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The natural history of multiple sclerosis].
    Confavreux C, Vukusic S.
    Rev Prat; 2006 Jun 30; 56(12):1313-20. PubMed ID: 16948219
    [Abstract] [Full Text] [Related]

  • 6. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H, Yinshan Zhao, Devonshire V.
    Mult Scler; 2008 Apr 30; 14(3):314-24. PubMed ID: 18208898
    [Abstract] [Full Text] [Related]

  • 7. Natural history of multiple sclerosis: risk factors and prognostic indicators.
    Vukusic S, Confavreux C.
    Curr Opin Neurol; 2007 Jun 30; 20(3):269-74. PubMed ID: 17495619
    [Abstract] [Full Text] [Related]

  • 8. The natural history of multiple sclerosis with childhood onset.
    Renoux C, Vukusic S, Confavreux C.
    Clin Neurol Neurosurg; 2008 Nov 30; 110(9):897-904. PubMed ID: 18534742
    [Abstract] [Full Text] [Related]

  • 9. The transition from relapsing-remitting MS to irreversible disability: clinical evaluation.
    Trojano M, Paolicelli D, Bellacosa A, Cataldo S.
    Neurol Sci; 2003 Dec 30; 24 Suppl 5():S268-70. PubMed ID: 14652786
    [Abstract] [Full Text] [Related]

  • 10. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.
    Arch Neurol; 2007 Aug 30; 64(8):1163-8. PubMed ID: 17698707
    [Abstract] [Full Text] [Related]

  • 11. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS.
    Neurology; 2007 Oct 09; 69(15):1498-507. PubMed ID: 17699802
    [Abstract] [Full Text] [Related]

  • 12. Natural history of multiple sclerosis with childhood onset.
    Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, Debouverie M, Brochet B, Lebrun-Frenay C, Pelletier J, Moreau T, Lubetzki C, Vermersch P, Roullet E, Magy L, Tardieu M, Suissa S, Confavreux C, Adult Neurology Departments KIDMUS Study Group.
    N Engl J Med; 2007 Jun 21; 356(25):2603-13. PubMed ID: 17582070
    [Abstract] [Full Text] [Related]

  • 13. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
    Skoog B, Runmarker B, Winblad S, Ekholm S, Andersen O.
    Brain; 2012 Mar 21; 135(Pt 3):900-11. PubMed ID: 22366800
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course.
    Bartolomei I, Salvi F, Galeotti R, Salviato E, Alcanterini M, Menegatti E, Mascalchi M, Zamboni P.
    Int Angiol; 2010 Apr 21; 29(2):183-8. PubMed ID: 20351674
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
    Glad SB, Nyland HI, Aarseth JH, Riise T, Myhr KM.
    Mult Scler; 2009 Aug 21; 15(8):942-50. PubMed ID: 19570821
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K, Khader Y.
    Clin Neurol Neurosurg; 2007 Jan 21; 109(1):32-7. PubMed ID: 16870328
    [Abstract] [Full Text] [Related]

  • 17. Benign multiple sclerosis in Crete.
    Mastorodemos V, Nikolakaki H, Tzagournissakis M, Kotzamani D, Panou T, Spanaki C, Klados G, Maris T, Kontolaimaki E, Psaroudaki K, Chlouverakis G, Georgakakis G, Plaitakis A.
    Mult Scler; 2010 Jun 21; 16(6):701-6. PubMed ID: 20237192
    [Abstract] [Full Text] [Related]

  • 18. [Young-onset multiple sclerosis].
    Silva A, Sá MJ.
    Rev Neurol; 2010 Jun 21; 28(11):1036-40. PubMed ID: 10390767
    [Abstract] [Full Text] [Related]

  • 19. Predictors of relapse rate in MS clinical trials.
    Held U, Heigenhauser L, Shang C, Kappos L, Polman C, Sylvia Lawry Centre for MS Research.
    Neurology; 2005 Dec 13; 65(11):1769-73. PubMed ID: 16344520
    [Abstract] [Full Text] [Related]

  • 20. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M, Neuhaus A, Morrissey S, Hintzen R, Ebers GC.
    Neurology; 2009 Feb 24; 72(8):705-11. PubMed ID: 19073945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 131.